Vyome Biosciences' Series C Round

Vyome Biosciences raised a round of funding on June 02, 2016. Investors include Romulus Capital.

Vyome Biosciences is a biopharmaceutical company leveraging next-generation functional genomics platforms, medicinal and polymer chemistry and nanotechnology to inspire the design and engineering of h…

Articles about Vyome Biosciences' Series C Round: